SPRY
#2820
ARS Pharmaceuticals, Inc. - Common Stock
6.0 3 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
+7.68%
6 month change
-32.55%
Year Change
-34.53%
Previous Close
6.0 3
Open
6.0 3
Low
6.0 3
High
6.0 3
Volume
63
Financials
- Market Capitalization 599.67 M
- Employee 200
- Founded 2015
- CEO N/A
- Website www.ars-pharma.com
- Headquarter Delaware, United States
- FIGI BBG00FZQGXG3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.7
Price to sales ratio
13.63
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2796 |  RGNX REGENXBIO Inc. - Common Stock | 9.37 USD | -0.11% | -15.89% | -2.90% | -30.23% | 618.54 M USD | ||
| 2814 |  ARVN Arvinas, Inc. - Common Stock | 9.24 USD | -0.86% | +2.44% | +12.96% | -0.65% | 604.17 M USD | ||
| 2838 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 10.06 USD | +7.48% | +47.94% | +227.69% | +60.19% | 584.88 M USD | ||
| 2841 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 11.94 USD | +1.44% | +6.04% | +11.69% | +187.02% | 583.75 M USD |
Frequently asked questions about ARS Pharmaceuticals, Inc. Common Stock
What is the ARS Pharmaceuticals, Inc. Common Stock stock price today?
The current price of ARS Pharmaceuticals, Inc. Common Stock (SPRY) is 6.03. Over the past 24 hours, the stock has changed by 0.00%. Follow the SPRY chart for real-time price dynamics.
What is the stock ticker of ARS Pharmaceuticals, Inc. Common Stock?
ARS Pharmaceuticals, Inc. Common Stock trades under the ticker SPRY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ARS Pharmaceuticals, Inc. Common Stock stock going up?
SPRY has changed by +9.24% over the last week, +7.68% over the last month, and -34.53% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of ARS Pharmaceuticals, Inc. Common Stock?
ARS Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 599.67 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were ARS Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, ARS Pharmaceuticals, Inc. Common Stock reported earnings of -0.63 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was ARS Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
ARS Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 33.66 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was ARS Pharmaceuticals, Inc. Common Stock net income for the last quarter?
ARS Pharmaceuticals, Inc. Common Stock reported net income of -62.34 M for the last quarter. The previous quarter showed -60.62 M, which means net income changed by -2.84%.
How many employees does ARS Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, ARS Pharmaceuticals, Inc. Common Stock has 200 employees. Workforce size can provide additional context about the company's scale and operations.
What is ARS Pharmaceuticals, Inc. Common Stock EBITDA?
ARS Pharmaceuticals, Inc. Common Stock EBITDA is -61.81 M, and its EBITDA margin is -183.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ARS Pharmaceuticals, Inc. Common Stock stock?
You can buy ARS Pharmaceuticals, Inc. Common Stock (SPRY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ARS Pharmaceuticals, Inc. Common Stock stock?
Investing in ARS Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SPRY chart and related analysis on metatrader.com as part of your research.